Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARATUMUMAB Cause Incorrect dose administered? 59 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Incorrect dose administered have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.2% of all adverse event reports for DARATUMUMAB.

59
Reports of Incorrect dose administered with DARATUMUMAB
0.2%
of all DARATUMUMAB reports
4
Deaths
19
Hospitalizations

How Dangerous Is Incorrect dose administered From DARATUMUMAB?

Of the 59 reports, 4 (6.8%) resulted in death, 19 (32.2%) required hospitalization, and 3 (5.1%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 59 reports have been filed with the FAERS database.

What Other Side Effects Does DARATUMUMAB Cause?

Plasma cell myeloma (2,980) Infusion related reaction (2,557) Off label use (2,494) Pneumonia (1,450) Neutropenia (1,351) Drug ineffective (1,110) Thrombocytopenia (1,089) Death (1,088) Pyrexia (1,032) Dyspnoea (996)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which DARATUMUMAB Alternatives Have Lower Incorrect dose administered Risk?

DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ DARATUMUMAB vs DARBEPOETIN ALFA DARATUMUMAB vs DARIDOREXANT DARATUMUMAB vs DARIFENACIN HYDROBROMIDE DARATUMUMAB vs DAROLUTAMIDE

Related Pages

DARATUMUMAB Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered DARATUMUMAB Demographics